Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of Fluobeam® LX Compared With Clinical Assessment of Parathyroid Glands to Counteract Postoperatively Failing Parathyroid Function With Low Blood Calcium After Thyroid Surgery

NCT04509011 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT04509011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04509011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of Fluobeam® LX Compared With Clinical Assessment of Parathyroid Glands to Counteract Postoperatively Failing Parathyroid Function With Low Blood Calcium After Thyroid Surgery
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2021
Completion date
July 31, 2023
Enrollment
516 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypoparathyroidism postprocedural